While an extreme situation – such as the current COVID-19 pandemic – can uncover weaknesses we weren’t aware of in some companies, it also serves to further highlight problems that existed before.
The latest round of cannabis earnings highlight the potential long-term impacts of current conditions, driven by back-to-back crises and other events.
It was a week of reckoning for many in the cannabis industry as the coronavirus outbreak has become the straw that broke the cash-challenged camel’s back – or the material adverse change companies are using to change plans made in different times.
It was a busy week for Harvest Health & Recreation (CSE: HARV), terminating its planned acquisition of Illinois-based Verano Holdings on Thursday and then announcing plans on Friday to acquire Franklin Labs.
This week, we saw our investment these play out: Companies with solid fundamental operations strategy will continue to be good investments even as public markets make wild swings.
Cannabis stocks aren’t immune from the wild swings of the broader public markets, but even in this bear market, we maintain our investment thesis for the industry.
Cannabis companies – both marijuana and hemp – were heating up the headlines this week. From Canada to Colorado and beyond, execs made big announcements and companies shifted gears.
We take a closer look at some of the key events from the past week, including news from Medicine Man Technologies, SOL Global and Acreage Holdings.
The cannabis industry continues its march toward maturity – something reflected in how companies have responded to the latest round of earnings results from the industry.
Another busy week in cannabis, with more executive changes and new financings as the cannabis industry continues to deal with unfunded cash burn.
Abrupt senior management changes are yellow flags that warrant further investigation by current and prospective investors. This week’s headlines offered many opportunities for such review.
